JPH09500109A
(ja)
*
|
1993-06-18 |
1997-01-07 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白質トランスフェラーゼの阻害剤
|
US5721236A
(en)
*
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US5700806A
(en)
*
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5856326A
(en)
*
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5801175A
(en)
*
|
1995-04-07 |
1998-09-01 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5712280A
(en)
*
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
IL117797A0
(en)
*
|
1995-04-07 |
1996-08-04 |
Pharmacopeia Inc |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
IL117798A
(en)
*
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
JPH11509204A
(ja)
*
|
1995-07-13 |
1999-08-17 |
ユニバーシテイ・オブ・シンシナテイ |
神経線維腫症の治療に有用な化合物
|
IL125062A
(en)
*
|
1995-12-22 |
2003-11-23 |
Schering Corp |
Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
US6028201A
(en)
*
|
1996-01-30 |
2000-02-22 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
WO1997031641A1
(en)
*
|
1996-02-29 |
1997-09-04 |
Duke University |
Method of treating hepatitis delta virus infection
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
US6451816B1
(en)
|
1997-06-20 |
2002-09-17 |
Klinge Pharma Gmbh |
Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
|
US5925757A
(en)
*
|
1996-07-26 |
1999-07-20 |
Schering Corporation |
Method for preparing carboxamides
|
PE92098A1
(es)
*
|
1996-07-31 |
1998-12-31 |
Schering Corp |
N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
|
SK33299A3
(en)
*
|
1996-09-13 |
2000-06-12 |
Schering Corp |
Tricyclic compounds useful for inhibition of farnesyl protein transferase
|
KR20000036102A
(ko)
*
|
1996-09-13 |
2000-06-26 |
둘락 노먼 씨. |
파르네실-단백질 트랜스퍼라제 억제제로서 유용한 치환된 벤조사이클로헵타피리딘
|
US5994364A
(en)
*
|
1996-09-13 |
1999-11-30 |
Schering Corporation |
Tricyclic antitumor farnesyl protein transferase inhibitors
|
US5861395A
(en)
*
|
1996-09-13 |
1999-01-19 |
Schering Corporation |
Compounds useful for inhibition of farnesyl proteins transferase
|
JP2001500507A
(ja)
*
|
1996-09-13 |
2001-01-16 |
シェーリング コーポレイション |
ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ピペリジニル化合物
|
IL128931A0
(en)
*
|
1996-09-13 |
2000-02-17 |
Schering Corp |
Tricylic antitumor compounds being farnesyl protein transferase inhibitors
|
US6071907A
(en)
*
|
1996-09-13 |
2000-06-06 |
Schering Corporation |
Tricyclic compounds useful as FPT inhibitors
|
US5985879A
(en)
*
|
1996-09-13 |
1999-11-16 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6030982A
(en)
*
|
1996-09-13 |
2000-02-29 |
Schering Corporationm |
Compounds useful for inhibition of farnesyl protein transferase
|
US6040305A
(en)
*
|
1996-09-13 |
2000-03-21 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
PL332242A1
(en)
*
|
1996-09-13 |
1999-08-30 |
Schering Corp |
Tricyclic inhibitors of proteinous farnesil transferase
|
ATE286044T1
(de)
*
|
1996-09-13 |
2005-01-15 |
Schering Corp |
Trizyklische verbindungen mit farnesyl protein transferase inhibierender wirkung
|
JP3152438B2
(ja)
*
|
1996-09-13 |
2001-04-03 |
シェーリング コーポレイション |
Gタンパク質機能の阻害および増殖性疾患の処置に有用な三環式化合物
|
US5965570A
(en)
*
|
1996-09-13 |
1999-10-12 |
Schering Corporation |
Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
|
US5958890A
(en)
*
|
1996-09-13 |
1999-09-28 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5945429A
(en)
*
|
1996-09-13 |
1999-08-31 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
EP1021448B1
(en)
*
|
1996-10-09 |
2003-05-02 |
Schering Corporation |
TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS
|
US6130229A
(en)
*
|
1996-10-09 |
2000-10-10 |
Schering Corporation |
Tricyclic compounds having activity as RAS-FPT inhibitors
|
US5760232A
(en)
*
|
1997-06-16 |
1998-06-02 |
Schering Corporation |
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
|
US6225322B1
(en)
|
1997-06-17 |
2001-05-01 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
DE69809238T2
(de)
*
|
1997-06-17 |
2003-09-18 |
Schering Corp |
Verbindungen als farnesyl-protein transferase inhibitoren
|
CA2293549C
(en)
*
|
1997-06-17 |
2008-08-05 |
Schering Corporation |
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
|
US5877177A
(en)
*
|
1997-06-17 |
1999-03-02 |
Schering Corporation |
Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5925639A
(en)
*
|
1997-06-17 |
1999-07-20 |
Schering Corporation |
Keto amide derivatives useful as farnesyl protein transferase inhibitors
|
WO1998057944A1
(en)
*
|
1997-06-17 |
1998-12-23 |
Schering Corporation |
Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
|
US6239140B1
(en)
|
1997-06-17 |
2001-05-29 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6051582A
(en)
*
|
1997-06-17 |
2000-04-18 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6576639B1
(en)
|
1997-06-17 |
2003-06-10 |
Schering Corporation |
Compounds for the inhibition of farnesyl protein transferase
|
IL133388A0
(en)
*
|
1997-06-17 |
2001-04-30 |
Schering Corp |
Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
|
US6211193B1
(en)
|
1997-06-17 |
2001-04-03 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6689789B2
(en)
|
1997-06-17 |
2004-02-10 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
AU8253498A
(en)
*
|
1997-06-17 |
1999-01-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
DE69825589T2
(de)
*
|
1997-06-17 |
2005-09-08 |
Schering Corp. |
Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung
|
US6218401B1
(en)
|
1997-06-17 |
2001-04-17 |
Schering Corporation |
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
|
US6159984A
(en)
*
|
1997-06-17 |
2000-12-12 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
US6228865B1
(en)
|
1997-06-17 |
2001-05-08 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US5925648A
(en)
*
|
1997-07-29 |
1999-07-20 |
Schering Corporation |
Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
|
US5958940A
(en)
*
|
1997-09-11 |
1999-09-28 |
Schering Corporation |
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
|
CA2305801A1
(en)
*
|
1997-10-10 |
1999-04-22 |
Schering Corporation |
Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo[5,6]cyclohepta [1,2-b]pyridin -11-ylidene)-1- piperidene carboxylate polymorph
|
DE19756235A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
|
DE19756261A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
|
DE19756212A1
(de)
*
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
|
US6903118B1
(en)
|
1997-12-17 |
2005-06-07 |
Klinge Pharma Gmbh |
Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
|
US6632455B2
(en)
|
1997-12-22 |
2003-10-14 |
Schering Corporation |
Molecular dispersion composition with enhanced bioavailability
|
WO2000001701A1
(en)
|
1998-07-02 |
2000-01-13 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
WO2000001382A1
(en)
|
1998-07-02 |
2000-01-13 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
EP1031564A1
(en)
|
1999-02-26 |
2000-08-30 |
Klinge Pharma GmbH |
Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy
|
PE20001566A1
(es)
|
1999-03-26 |
2001-02-05 |
Ucb Sa |
Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
|
US6686502B1
(en)
|
1999-03-26 |
2004-02-03 |
Ucb S.A. |
Compounds and methods for treatment of asthma, allergy and inflammatory disorders
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
US6441017B1
(en)
*
|
1999-09-09 |
2002-08-27 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
US7074921B2
(en)
|
2001-11-13 |
2006-07-11 |
Bristol Myers Squibb Company |
Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds
|
PT1507531E
(pt)
*
|
2003-03-12 |
2007-03-30 |
Teva Pharma |
Composições farmacêuticas estáveis de desloratadina
|
WO2005017160A2
(en)
|
2003-08-13 |
2005-02-24 |
Children's Hospital Medical Center |
Mobilization of hematopoietic cells
|
ES2382814T3
(es)
|
2005-05-17 |
2012-06-13 |
Merck Sharp & Dohme Ltd. |
Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
|
AU2006306499A1
(en)
*
|
2005-10-21 |
2007-05-03 |
Merck Sharp & Dohme Corp. |
Tyrosine kinase inhibitors
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
EA018917B1
(ru)
|
2006-04-19 |
2013-11-29 |
Новартис Аг |
6-о-замещенные бензоксазолы и бензотиазолы и способы подавления передачи сигналов от csf-1r
|
CA2770486C
(en)
|
2006-09-22 |
2014-07-15 |
Merck Sharp & Dohme Corp. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
PL2109608T3
(pl)
|
2007-01-10 |
2011-08-31 |
Msd Italia Srl |
Indazole podstawione grupą amidową jako inhibitory polimerazy poli(ADP-rybozy)-(PARP)
|
US8822497B2
(en)
|
2007-03-01 |
2014-09-02 |
Novartis Ag |
PIM kinase inhibitors and methods of their use
|
WO2008144062A1
(en)
|
2007-05-21 |
2008-11-27 |
Novartis Ag |
Csf-1r inhibitors, compositions, and methods of use
|
JP5501227B2
(ja)
|
2007-06-27 |
2014-05-21 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ヒストンデアセチラーゼ阻害剤としての4−カルボキシベンジルアミノ誘導体
|
WO2010114780A1
(en)
|
2009-04-01 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
WO2010144909A1
(en)
|
2009-06-12 |
2010-12-16 |
Novartis Ag |
Fused heterocyclic compounds and their uses
|
US8859776B2
(en)
|
2009-10-14 |
2014-10-14 |
Merck Sharp & Dohme Corp. |
Substituted piperidines that increase p53 activity and the uses thereof
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
AU2011227643A1
(en)
|
2010-03-16 |
2012-09-20 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
EP2584903B1
(en)
|
2010-06-24 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Novel heterocyclic compounds as erk inhibitors
|
JP6043285B2
(ja)
|
2010-08-02 |
2016-12-14 |
サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. |
低分子干渉核酸(siNA)を用いたカテニン(カドヘリン結合型タンパク質)β1(CTNNB1)遺伝子発現のRNA干渉媒介性阻害
|
RU2624045C2
(ru)
|
2010-08-17 |
2017-06-30 |
Сирна Терапьютикс,Инк |
ОПОСРЕДУЕМОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНОВ ВИРУСА ГЕПАТИТА B (HBV) С ПРИМЕНЕНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК)
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
EP2613782B1
(en)
|
2010-09-01 |
2016-11-02 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as erk inhibitors
|
US9242981B2
(en)
|
2010-09-16 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel ERK inhibitors
|
EP2632472B1
(en)
|
2010-10-29 |
2017-12-13 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina)
|
WO2012087772A1
(en)
|
2010-12-21 |
2012-06-28 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
CN103732592A
(zh)
|
2011-04-21 |
2014-04-16 |
默沙东公司 |
胰岛素样生长因子-1受体抑制剂
|
US9023865B2
(en)
|
2011-10-27 |
2015-05-05 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
US9382239B2
(en)
|
2011-11-17 |
2016-07-05 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-terminal kinase (JNK)
|
US20150299696A1
(en)
|
2012-05-02 |
2015-10-22 |
Sirna Therapeutics, Inc. |
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
|
CA2882950A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Novel compounds that are erk inhibitors
|
WO2014063068A1
(en)
|
2012-10-18 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
RU2660349C2
(ru)
|
2012-11-28 |
2018-07-05 |
Мерк Шарп И Доум Корп. |
Композиции и способы для лечения злокачественной опухоли
|
WO2014100065A1
(en)
|
2012-12-20 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Substituted imidazopyridines as hdm2 inhibitors
|
WO2014120748A1
(en)
|
2013-01-30 |
2014-08-07 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as hdm2 inhibitors
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
US10047070B2
(en)
|
2013-10-18 |
2018-08-14 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
EP3057955B1
(en)
|
2013-10-18 |
2018-04-11 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
AU2015371251B2
(en)
|
2014-12-23 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2016160617A2
(en)
|
2015-03-27 |
2016-10-06 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
EP3307728A4
(en)
|
2015-06-12 |
2019-07-17 |
Dana Farber Cancer Institute, Inc. |
ASSOCIATION THERAPY USING TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS
|
CA2996978A1
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
EP3609922A2
(en)
|
2017-04-13 |
2020-02-19 |
Aduro Biotech Holdings, Europe B.V. |
Anti-sirp alpha antibodies
|
EP3706742B1
(en)
|
2017-11-08 |
2023-03-15 |
Merck Sharp & Dohme LLC |
Prmt5 inhibitors
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
WO2020033282A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
US20210309688A1
(en)
|
2018-08-07 |
2021-10-07 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|